BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yap DYH, Chan TM. Evolution of hepatitis B management in kidney transplantation. World J Gastroenterol 2014; 20(2): 468-474 [PMID: 24574715 DOI: 10.3748/wjg.v20.i2.468]
URL: https://www.wjgnet.com/1007-9327/full/v20/i2/468.htm
Number Citing Articles
1
Mohammed Rafique Moosa, Jonathan David Maree, Maxwell T. Chirehwa, Solomon R. Benatar, Jaap A. Joles. Use of the ‘Accountability for Reasonableness’ Approach to Improve Fairness in Accessing Dialysis in a Middle-Income CountryPLOS ONE 2016; 11(10): e0164201 doi: 10.1371/journal.pone.0164201
2
Charat Thongprayoon, Wisit Kaewput, Konika Sharma, Karn Wijarnpreecha, Napat Leeaphorn, Patompong Ungprasert, Ankit Sakhuja, Franco H Cabeza Rivera, Wisit Cheungpasitporn. Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysisWorld Journal of Hepatology 2018; 10(2): 337-346 doi: 10.4254/wjh.v10.i2.337
3
Jing Liang, Chaoyang Lv, Minling Chen, Ming Xu, Chenhe Zhao, Yinqiu Yang, Jina Wang, Dong Zhu, Jian Gao, Ruiming Rong, Tongyu Zhu, Mingxiang Yu. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantationJournal of Diabetes 2019; 11(5): 370 doi: 10.1111/1753-0407.12853
4
Sarah Schrauben, Jeffrey S. Berns. National Kidney Foundation' s Primer on Kidney Diseases2018; : 225 doi: 10.1016/B978-0-323-47794-9.00023-8
5
Giuseppe Coppolino, Mariadelina Simeoni, Chiara Summaria, Maria Concetta Postorino, Laura Rivoli, Alessio Strazzulla, Carlo Torti, Giorgio Fuiano. The case of chronic hepatitis B treatment with tenofovir: an update for nephrologistsJournal of Nephrology 2015; 28(4): 393 doi: 10.1007/s40620-015-0214-0
6
C. Ng, R. Danguilan, G. Pamugas, E. Que. Outcomes of Renal Allograft Recipients With Hepatitis B From January 2000 to December 2010Transplantation Proceedings 2018; 50(10): 3242 doi: 10.1016/j.transproceed.2018.07.028
7
Apurva S. Shah, Deepak N. Amarapurkar. Spectrum of hepatitis B and renal involvementLiver International 2018; 38(1): 23 doi: 10.1111/liv.13498
8
E. Durante‐Mangoni, M. Vitrone, A. Parrella, R. Andini, D. Iossa, E. Ragone, E. Falco, C. Maiello, R. Utili, R. Zampino. Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipientsTransplant Infectious Disease 2016; 18(3): 319 doi: 10.1111/tid.12525
9
Massimiliano Veroux, Vincenzo Ardita, Daniela Corona, Alessia Giaquinta, Burcin Ekser, Nunziata Sinagra, Domenico Zerbo, Marco Patanè, Cecilia Gozzo, Pierfrancesco Veroux. Kidney Transplantation From Donors with Hepatitis BMedical Science Monitor 2016; 22: 1427 doi: 10.12659/MSM.896048
10
Kevin Lu, Kun-Yuan Chiu. Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV InfectionTransplantation Proceedings 2023; 55(7): 1581 doi: 10.1016/j.transproceed.2023.05.017
11
Ezequiel Ridruejo. Antiviral treatment for chronic hepatitis B in renal transplant patientsWorld Journal of Hepatology 2015; 7(2): 189-203 doi: 10.4254/wjh.v7.i2.189
12
Mythili Ghanta, Belinda Jim. Renal Transplantation in Advanced Chronic Kidney Disease PatientsMedical Clinics of North America 2016; 100(3): 465 doi: 10.1016/j.mcna.2015.12.003
13
Kevin Lu, Kun-Yuan Chiu. Comparative Survival Analysis of Dialysis and Renal Transplantation in HBV-Infected End-Stage Renal Disease PatientsTransplantation Proceedings 2023; 55(10): 2429 doi: 10.1016/j.transproceed.2023.09.015
14
SnehaHaridas Anupama, Rajeevalochana Parthasarathy, Milly Mathew, PriyaHaridas Anupama, Georgi Abraham. Rectal carcinoma 27 years' postkidney transplant in a chronic hepatitis B patient - A case reportIndian Journal of Transplantation 2022; 16(1): 135 doi: 10.4103/ijot.ijot_128_20
15
V.T. Yilmaz, İ. Aliosmanoglu, H. Erbis, B.V. Ulger, R. Cetinkaya, G. Suleymanlar, H. Kocak. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(−) donorsTransplant Infectious Disease 2016; 18(1): 55 doi: 10.1111/tid.12482